Nabriva Therapeutics plc Depreciation & Amortization 2011-2026 | NBRV

Annual Depreciation & Amortization Nabriva Therapeutics plc

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
217 K	356 K	417 K	396 K	510 K	432 K	233 K	153 K	166 K	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
510 K	153 K	320 K

Quarterly Depreciation & Amortization Nabriva Therapeutics plc

2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
39 K	21 K	-	192 K	155 K	78 K	-	270 K	188 K	99 K	-	315 K	209 K	103 K	-	162 K	245 K	125 K	-	391 K	262 K	133 K	-	295 K	149 K	76 K	-	172 K	99 K	45 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
391 K	21 K	166 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Happiness Biotech Group Limited HAPP	380 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Coherus BioSciences CHRS	1.3 M	$ 1.69	2.74 %	$ 198 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Celldex Therapeutics CLDX	3.38 M	$ 31.56	2.29 %	$ 2.1 B	USA
CRISPR Therapeutics AG CRSP	19.5 M	$ 53.73	4.15 %	$ 4.83 B	Schweiz
AstraZeneca PLC AZN	5.73 B	-	-	$ 96.9 B	Britain
Athira Pharma ATHA	972 K	-	-	$ 269 M	USA
Compugen Ltd. CGEN	475 K	$ 2.74	3.46 %	$ 256 M	Israel
Galera Therapeutics GRTX	20 K	-	-32.59 %	$ 7.61 M	USA
Enlivex Therapeutics Ltd. ENLV	332 K	$ 0.76	11.14 %	$ 34.7 M	Israel
Esperion Therapeutics ESPR	105 K	$ 3.13	0.32 %	$ 651 M	USA
Eton Pharmaceuticals ETON	4.04 M	$ 32.33	3.32 %	$ 870 M	USA
Forte Biosciences FBRX	64 K	$ 21.58	-1.64 %	$ 279 M	USA
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
Galectin Therapeutics GALT	1 K	$ 2.71	-2.87 %	$ 173 M	USA
Generation Bio Co. GBIO	4.93 M	-	-	$ 344 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Hutchison China MediTech Limited HCM	13.3 M	$ 11.68	-0.6 %	$ 10 B	China
Heron Therapeutics HRTX	2.31 M	$ 0.91	3.18 %	$ 152 M	USA
Cyclacel Pharmaceuticals CYCCP	5 K	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	1.74 M	-	-	$ 384 M	Britain
ImmuCell Corporation ICCC	2.78 M	$ 10.49	-0.1 %	$ 94.7 M	USA
Gracell Biotechnologies GRCL	58.8 M	-	-	$ 3.37 B	China
Anika Therapeutics ANIK	5.37 M	$ 14.72	-1.12 %	$ 211 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 3.35	-2.62 %	$ 5.51 M	Israel